Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Environmental Health Perspectives|March 25, 1999
Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulinA O Cheek, K Kow, J Chen, et al.
Veterinary and Comparative Oncology|May 19, 2012
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell linesS E Lyles, R J Milner, K Kow, et al.
Experimental Neurology|June 1, 1997
Regulation by interleukin-1beta of formation of a line of delimiting astrocytes following prenatal trauma to the brain of the mouseJ L Scripter, J Ko, K Kow, et al.
Veterinary and Comparative Oncology|September 17, 2009
Telomerase activity in canine osteosarcomaK Kow, S M Bailey, E S Williams, et al.
Veterinary and Comparative Oncology|July 1, 2014
In vitro effects of Yunnan Baiyao on canine hemangiosarcoma cell linesK A Wirth, K Kow, M E Salute, et al.
Veterinary Journal (London, England : 1997)|February 22, 2011
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept studyD H Thamm, B Rose, K Kow, et al.
Journal of Veterinary Internal Medicine|September 3, 2008
Impact of telomerase status on canine osteosarcoma patientsK Kow, D H Thamm, J Terry, et al.
Preventive Veterinary Medicine|January 23, 2016
Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysisA F Schmidt, R H H Groenwold, P Amsellem, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Environmental Health Perspectives|March 25, 1999
Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulinA O Cheek, K Kow, J Chen, et al.
Veterinary and Comparative Oncology|May 19, 2012
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell linesS E Lyles, R J Milner, K Kow, et al.
Experimental Neurology|June 1, 1997
Regulation by interleukin-1beta of formation of a line of delimiting astrocytes following prenatal trauma to the brain of the mouseJ L Scripter, J Ko, K Kow, et al.
Veterinary and Comparative Oncology|September 17, 2009
Telomerase activity in canine osteosarcomaK Kow, S M Bailey, E S Williams, et al.
Veterinary and Comparative Oncology|July 1, 2014
In vitro effects of Yunnan Baiyao on canine hemangiosarcoma cell linesK A Wirth, K Kow, M E Salute, et al.
Veterinary Journal (London, England : 1997)|February 22, 2011
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept studyD H Thamm, B Rose, K Kow, et al.
Journal of Veterinary Internal Medicine|September 3, 2008
Impact of telomerase status on canine osteosarcoma patientsK Kow, D H Thamm, J Terry, et al.
Preventive Veterinary Medicine|January 23, 2016
Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysisA F Schmidt, R H H Groenwold, P Amsellem, et al.
Pageof 1